01110.HK
Kingworld Medicines Group Limited
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 0.42
+3.70%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.7B | 917.3M | 1.1B | 1.1B | 957.7M |
| Cost of Revenue | 1.2B | 669.4M | 790.6M | 798.0M | 680.1M |
| Gross Profit | 474.0M | 247.9M | 270.4M | 280.7M | 277.6M |
| Operating Expenses | |||||
| R&D Expense | 44.7M | 21.8M | 17.6M | 18.8M | 15.5M |
| SG&A Expense | 361.4M | 177.0M | 189.5M | 222.3M | 205.0M |
| General & Admin Expense | 202.7M | 99.2M | 90.7M | 119.5M | 104.6M |
| Selling & Marketing Expense | 158.7M | 77.7M | 98.8M | 102.8M | 100.5M |
| Other Expenses | (34.9M) | (14.0M) | (26.3M) | (57.3M) | (15.2M) |
| Total Operating Expenses | 371.2M | 184.7M | 180.7M | 183.9M | 205.4M |
| Cost and Expenses | 1.6B | 854.2M | 971.4M | 981.9M | 885.5M |
| Operating Income (EBIT) | 115.0M | 63.2M | 89.7M | 96.8M | 72.2M |
| Non-Operating | |||||
| Interest Income | 9.4M | 4.7M | 6.3M | 2.4M | 1.5M |
| Interest Expense | 19.3M | 14.0M | 13.3M | 11.5M | 12.3M |
| Net Interest Income | (13.3M) | (9.3M) | (4.9M) | (9.1M) | (10.8M) |
| Other Non-Op Income/Expense | (1.8M) | (5.7M) | 5.8M | (2.9M) | (4.7M) |
| Non-Operating Income (excl Interest) | 3.5M | 6.5M | (911.0K) | (8.6M) | (7.6M) |
| EBT (Pre-Tax Income) | 113.2M | 57.4M | 95.5M | 93.9M | 67.6M |
| Income Tax Expense | 37.9M | 18.5M | 21.1M | 32.3M | 24.0M |
| Bottom Line | |||||
| Net Income | 16.9M | 11.3M | 41.6M | 38.1M | 22.7M |
| Earnings from Cont. Ops | 75.3M | 38.9M | 74.5M | 61.6M | 43.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 17.0M | 11.3M | 41.6M | 38.1M | 22.7M |
| Per Share | |||||
| Basic EPS | HK$0.03 | HK$0.02 | HK$0.07 | HK$0.06 | HK$0.04 |
| Diluted EPS | HK$0.03 | HK$0.02 | HK$0.07 | HK$0.06 | HK$0.04 |
| Revenue Per Share | HK$2.96 | HK$1.57 | HK$1.84 | HK$1.82 | HK$1.58 |
| Shares | |||||
| Basic Shares Outstanding | 583.3M | 586.2M | 575.9M | 591.6M | 606.7M |
| Diluted Shares Outstanding | 583.3M | 586.2M | 575.9M | 591.6M | 622.5M |
| Profitability Metrics | |||||
| EBITDA | 131.7M | 72.0M | 100.5M | 125.5M | 118.1M |
| D&A | 32.4M | 15.3M | 9.8M | 20.1M | 38.2M |
| EBIT | 99.3M | 56.7M | 90.6M | 105.4M | 79.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026